On the market, sectors such as coal, utilities, environmental protection, agriculture, forestry, animal husbandry and fishing, petroleum and petrochemicals, and basic chemicals registered the highest gains, while real estate, non-ferrous metals, defense and military, beauty and care, household appliances, and power equipment weakened.
Overnight, the US PMI data once again dampened expectations of interest rate cuts. The three major indices of the US stock market fell sharply. The Chinese index plummeted 4% and fell for 4 consecutive days. This morning, A-shares opened flat, Hong Kong stocks opened lower, and large technology stocks listed on Hong Kong stocks continued to collectively decline.
As of press release, the Shanghai Index and Shenzhen Index are trading sideways, and the GEM Index is up 0.2%.
On the market, sectors such as coal, utilities, environmental protection, agriculture, forestry, animal husbandry and fishing, petroleum and petrochemicals, and basic chemicals registered the highest gains, while real estate, non-ferrous metals, defense and military, beauty and care, household appliances, and power equipment weakened.
The Hang Seng Index fell 0.52%, while the Hang Ke Index fell 0.78%.
The performance of Hong Kong stocks, science and network stocks is sluggish
Of the top five ATMXJ technology stocks, only Ali, which plummeted yesterday due to the issuance of convertible bonds, rebounded. Yesterday, after announcing earnings reports that exceeded expectations, revenue increased by 30%, and Xiaomi's results, which doubled year-on-year profits, fell 1%. JD, Tencent, and Meituan all declined.
Station B, whose net loss increased 21.4% year on year in the previous quarter, plummeted nearly 10%. NetEase reversed the market by 4% and led the Hang Seng Index and Hengke Index. Last quarter's revenue increased 7.2% year on year, and net profit increased 13% year on year.
Real estate stocks plummeted
Vanke A fell by about 4%, urban construction development came to a standstill, and Chongqing Development, Binjiang, and Jindi fell by more than 5%.
Hong Kong domestic housing stocks generally fell. Jinhui Holdings fell more than 7%, followed by Yuexiu, Longhu, Greentown, and Vanke.
The biomedical sector of Hong Kong stocks fell sharply
Innovative drug manufacturer Kangfang Biotech initially plummeted by 24%, while BeiGene Shenzhou, Zaiding Pharmaceuticals, and Kingsley fell more than 5%.
According to the news, Kangfang Biotech's AK112 and EGFR-TKI treated non-small cell lung cancer stage III clinical data in China fell short of expectations.
The A-share synthetic biology concept fluctuates and rebounds
Sunda Biotech went up and down, while Bohn Group, Kyodo Pharmaceuticals, Fujilai, and Azure Biotech followed suit.
According to the news, Beijing released the “Beijing Action Plan to Accelerate Collaborative Innovation in Medicine and Health (2024-2026)”, which proposes to deploy “nuclear explosion point” projects in cutting-edge technology fields such as cell-gene therapy, brain-computer interface, and synthetic biology.
The consumer electronics sector fluctuated higher
Longyang Electronics rose and stopped by 20cm, Hongfuhan and Bestak rose more than 10%, and Yidong Electronics, Kaiwang Technology, and Feirongda followed suit.
The A-share carbon trading sector is active in the intraday
The development of New China, Hong Kong, and Hunan all came to a standstill. Many stocks such as Huayin Electric Power, Jingwei Co., Ltd., Pino Technology, and Baichuan Changyin rose more than 5%.
Hong Kong power stocks rallied
Longyuan Electric Power rose more than 7%, Datang New Energy rose more than 6%, and China Electric Power rose more than 5%.
(being updated)